ECG Buddy Clinic: CVD Risk AI

Supports screening of hidden high-risk cardiovascular patients in outpatient care, from a single 12-lead ECG. ECG Buddy Clinic is a Korean MFDS-approved Class III software medical device. Capture a 12-lead ECG with your smartphone, and the AI provides an estimated LVEF and risk scores for 4 digital biomarkers. It reveals possible structural and functional abnormalities beyond standard ECG interpretation, and supports decisions on follow-up tests such as echocardiography or coronary CT. [Estimated LVEF] • Estimated LVEF (%) from the ECG alone • A key reference for identifying heart failure risk and reduced LV systolic function [4 Digital Biomarkers] • CADS: coronary artery disease with ≥50% stenosis • PAF: paroxysmal AF risk from sinus rhythm ECGs • LVH: a major complication of chronic hypertension • HCM: a cause of sudden cardiac death • Risk levels shown at a glance in a graph [Easy to Use] • Automatic ECG area detection on the camera screen • Works with printed ECGs, ECGs on monitors, and saved ECG images • No extra equipment or hospital system integration needed [Validated Technology] • Korean MFDS-approved Class III medical device • Validated in 6 peer-reviewed papers, including Heart Rhythm and European Heart Journal Digital Health • ISO 27001 and ISO 27701 certified [Usage Policy] • Up to 10 analyses per day • Subject to change with prior notice if a subscription is introduced [Precautions] • Please read the "Instructions for Use" before clinical application. • Clinical use is restricted to countries where regulatory approval has been granted (Republic of Korea, Vietnam). For educational and research purposes, use should be limited to post-case reviews and educational interpretations. • For clinical use, this device is intended for physicians capable of interpreting 12-lead ECGs or medical personnel who transmit results to such physicians. • This tool is designed to support diagnostic and treatment decisions and can never replace the professional medical judgment of a physician. *For any inquiries or for more information, please visit our website (www.arpi.ai).